Search - tctmd.com

February 18, 2026

News Daily News

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

February 06, 2026

News Daily News

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

February 02, 2026

News Daily News

Heart Disease Remains Number One Killer of Americans

January 22, 2026

News Daily News

JACC Debuts Data Digest on CV Health in the United States

January 12, 2026

News Daily News

Statins Work for Primary Prevention Even in Low-risk Patients With Type 2 Diabetes

Todd Neale

January 05, 2026

News Daily News

Year in Review: Top Prevention Stories of 2025

December 24, 2025

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

December 18, 2025

News Daily News

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

October 22, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

August 01, 2025

News Daily News

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

July 31, 2025

News Daily News

GLP-1s May Stave Off Dementia, EHR-Based Study Shows

July 21, 2025

News Daily News

Majority of US Adults Have High Long-term Risk of CVD: NHANES

June 13, 2025

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

February 20, 2025

News Daily News

CVD Hospitalization in Older Adults Higher in US Than in Denmark

February 07, 2025

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

January 22, 2025

News Daily News

Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates

January 10, 2025

News Daily News

Top General Cardiology and Prevention News of 2024

December 30, 2024

News Daily News

Increased CVD Risk Seen Up to 30 Years Before Type 2 Diabetes Diagnosis

Todd Neale

November 28, 2024

News Daily News

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients